Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O F Ramos

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Cancer Research|May 1, 1984
Activation of cytotoxic activity of human blood lymphocytes by tumor-promoting compoundsO F Ramos, M G Masucci, E Klein
Cellular Immunology|March 1, 1985
Modulation of human blood lymphocyte cytotoxicity by the phorbol ester tumor promoter P(Bu)2: increase of target binding, impairment of effector recycling, and activation of lytic potential which is independent of IL-2O F Ramos, M G Masucci, E Klein
Complement and Inflammation|January 1, 1991
Activation and fixation of C3 by human B cell lines is enhanced by interferon-gamma and tumor necrosis factor alphaE Yefenof, I Algarra, O F Ramos, et al.
Cellular Immunology|October 1, 1989
Lysis of P3HR-1 cells induced to enter the viral cycle by antibody-dependent and independent immunological mechanismsS Kurakata, O F Ramos, G Klein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1989
Requirement of leukocytic cell adhesion molecules (CD11a-c/CD18) in the enhanced NK lysis of iC3b-opsonized targetsO F Ramos, M Patarroyo, E Yefenof, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1988
The elevated natural killer sensitivity of targets carrying surface-attached C3 fragments require the availability of the iC3b receptor (CR3) on the effectorsO F Ramos, C Kai, E Yefenof, et al.
Immunology Letters|June 15, 1989
Ligands of CR2 do not interfere with C3 fragment fixation or enhanced NK sensitivity of Raji cells treated with human serumE Yefenof, O F Ramos, B Nilsson, et al.
Haematologia|December 1, 1981
Platelet function abnormalities in acute leukaemiaO F Ramos, E C Morón, R De Castro Arenas
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1985
Complement-dependent cellular cytotoxicity: lymphoblastoid lines that activate complement component 3 (C3) and express C3 receptors have increased sensitivity to lymphocyte-mediated lysis in the presence of fresh human serumO F Ramos, G Sármay, E Klein, et al.
European Journal of Immunology|July 1, 1987
Alternative pathway of complement activation by stimulated T lymphocytes. I. Binding of C3 fragmentsG Sármay, O F Ramos, E Klein, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cancer Research|May 1, 1984
Activation of cytotoxic activity of human blood lymphocytes by tumor-promoting compoundsO F Ramos, M G Masucci, E Klein
Cellular Immunology|March 1, 1985
Modulation of human blood lymphocyte cytotoxicity by the phorbol ester tumor promoter P(Bu)2: increase of target binding, impairment of effector recycling, and activation of lytic potential which is independent of IL-2O F Ramos, M G Masucci, E Klein
Complement and Inflammation|January 1, 1991
Activation and fixation of C3 by human B cell lines is enhanced by interferon-gamma and tumor necrosis factor alphaE Yefenof, I Algarra, O F Ramos, et al.
Cellular Immunology|October 1, 1989
Lysis of P3HR-1 cells induced to enter the viral cycle by antibody-dependent and independent immunological mechanismsS Kurakata, O F Ramos, G Klein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1989
Requirement of leukocytic cell adhesion molecules (CD11a-c/CD18) in the enhanced NK lysis of iC3b-opsonized targetsO F Ramos, M Patarroyo, E Yefenof, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1988
The elevated natural killer sensitivity of targets carrying surface-attached C3 fragments require the availability of the iC3b receptor (CR3) on the effectorsO F Ramos, C Kai, E Yefenof, et al.
Immunology Letters|June 15, 1989
Ligands of CR2 do not interfere with C3 fragment fixation or enhanced NK sensitivity of Raji cells treated with human serumE Yefenof, O F Ramos, B Nilsson, et al.
Haematologia|December 1, 1981
Platelet function abnormalities in acute leukaemiaO F Ramos, E C Morón, R De Castro Arenas
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1985
Complement-dependent cellular cytotoxicity: lymphoblastoid lines that activate complement component 3 (C3) and express C3 receptors have increased sensitivity to lymphocyte-mediated lysis in the presence of fresh human serumO F Ramos, G Sármay, E Klein, et al.
European Journal of Immunology|July 1, 1987
Alternative pathway of complement activation by stimulated T lymphocytes. I. Binding of C3 fragmentsG Sármay, O F Ramos, E Klein, et al.
Pageof 2